Early heartburn relief with proton pump inhibitors: A systematic review and meta-analysis of clinical trials

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 6, 2005, Pages 553-563

  Mcquaid, Kenneth R ^a,b,d   Laine, Loren ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROTON PUMP INHIBITOR;

BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DOSE CALCULATION; DRUG EFFECT; DRUG EFFICACY; HEARTBURN; HUMAN; INFORMATION RETRIEVAL; MEDICAL INFORMATION; META ANALYSIS; RANDOMIZATION; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 20444473674     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00023-6     Document Type: Article

References (52)

1. The Gallup Organization A Gallup Organization national surgery heartburn across America 1988 The Gallup Organization, Inc Princeton, NJ
2. B. van Pinxteren, M. Numans, J. Lau Short-term treatment of gastroesophageal reflux disease a systematic review and meta-analysis of the effect of acid-suppressant drugs in empirical treatment and in endoscopy-negative patients J Gen Intern Med 18 2003 755 763
3. J. Dent, J. Brun, A.M. Fendrick An evidence-based appraisal of reflux disease management the Genval Workshop Report Gut 44 1999 S1 S16
4. K.R. DeVault, D.O. Castell The Practice Parameters Committee of the American College of Gastroenterology Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 94 1999 1434 1442
5. G.N. Tytgat Review article management of mild and severe gastro-oesophageal reflux disease Aliment Pharmacol Ther 17 2003 52 56
6. P. Bytzer Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease Am J Gastroenterol 98 2003 S31 S39
7. R. Dekel, C. Morse, R. Fass The role of proton pump inhibitors in gastro-oesophageal reflux disease Drugs 64 2004 277 295
8. P. Maton Omeprazole N Engl J Med 324 1991 965 975
9. P. Richardson, C. Hawkey, W. Stack Proton pump inhibitors pharmacology and rationale for use in gastrointestinal disorders Drugs 56 1998 307 335
10. M.P. Williams, J. Sercombe, M.I. Hamilton A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24 hour intragastric acidity and plasma gastrin concentration in young healthy male subjects Aliment Pharmacol Ther 12 1998 307 334
11. M. Hartmann, U. Theiss, R. Huber Twenty-four hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump pantoprazole in comparison to omeprazole Aliment Pharmacol Ther 10 1996 359 366
12. J.Q. Huang, D.R. Goldwater, A.B. Thomson Acid suppression in healthy subjects following lansoprazole or pantoprazole Aliment Pharmacol Ther 16 2002 425 433
13. C. Florent, S. Forestier Twenty-four hour monitoring of intragastric acidity comparison between lansoprazole 30 mg and pantoprazole 40 mg Eur J Gastroenterol Hepatol 9 1997 195 200
14. J.G. Hatlebakk Review article gastric acidity-comparison of esomeprazole with other proton pump inhibitors Aliment Pharmacol Ther 17 2003 10 15
15. N. Chiba, C.J. De Gara, J. Wilkinson Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease a meta-analysis Gastroenterology 112 1997 1798 1810
16. N. Sharma, C. Donnellan, C. Preston A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials Gut 53 2004 iv58 iv65
17. B. van Pinxteren, M.E. Numans, P.A. Bonis Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux-like symptoms and endoscopy negative reflux disease (Cochrane Review) The Cochrane Library 2004 John Wiley & Sons, Ltd Chichester, UK
18. A.R. Jadad, R.A. Moore, D. Carroll Assessing the quality of reports of randomized clinical trials is blinding necessary? Control Clin Trials 17 1996 1 12
19. K. Adachi, T. Hashimoto, N. Hamamoto Symptom relief in patients with reflux esophagitis comparative study of omeprazole, lansoprazole, and rabeprazole J Gastroenterol Hepatol 18 2003 1392 1398
20. D.O. Castell, P.J. Kahrilas, J.E. Richter Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagititis Am J Gastroenterol 97 2002 575 583
21. D.O. Castell, J.E. Richter, M. Robinson Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis Am J Gastroenterol 91 1996 1749 1757
22. W. Chey, B. Buang, R. Jackson Lansoprazole and esomeprazole in symptomatic GERD a double-blind, randomized, multicentre trial in 3000 patients confirms comparable symptom relief Clin Drug Invest 23 2003 69 84
23. G. Holtmann, P. Bytzer, M. Metz A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 2002 479 485
24. C. Howden, E. Ballard, W. Robieson Evidence for therapeutic equivalence of lansoprazole 30 mg and esomeprazole 40 mg in the treatment of erosive oesophagitis Clin Drug Invest 22 2002 99 109
25. F. Johnsson, J.G. Hatlebakk, A.C. Klintenberg Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn Scand J Gastroenterol 38 2003 347 353
26. P.J. Kahrilas, G.W. Falk, D.A. Johnson Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients a randomized controlled trial-the Esomeprazole Study Investigators Aliment Pharmacol Ther 12 2000 1249 1258
27. P.O. Katz, D.O. Castell, D. Levine Esomeprazole resolves chronic heartburn in patients without erosive esophagitis Aliment Pharmacol Ther 18 2003 875 882
28. P.J. Miner, W. Orr, J. Filippone Rabeprazole in nonerosive gastroesophageal reflux disease a randomized placebo-controlled trial Am J Gastroenterol 97 2002 1332 1339
29. J.E. Richter, P.J. Kahrilas, J. Johanson Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis a randomized controlled trial Am J Gastroenterol 96 2001 656 665
30. J.E. Richter, P.J. Kahrilas, S.J. Sontag Comparing lansoprazole and omeprazole in onset of heartburn relief results of a randomized, controlled trial in erosive esophagitis patients Am J Gastroenterol 96 2001 3089 3098
31. J.E. Richter, T.O. Kovacs, P.A. Greski-Rose Lansoprazole in the treatment of heartburn in patients without erosive esophagitis Aliment Pharmacol Ther 13 1999 795 804
32. J.E. Richter, D. Peura, S.B. Benjamin Efficacy of omeprazole for the treatment of symptomatic reflux disease without esophagitis Arch Intern Med 160 2000 1810 1816
33. M. Robinson, D.L. Decktor, P.N. Maton Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive esophagitis Aliment Pharmacol Ther 7 1993 67 73
34. M. Robinson, S. Fitzgerald, R. Hegedus Onset of symptom relief with rabeprazole a community-based open-label assessment of patients with erosive esophagitis Aliment Pharmacol Ther 16 2002 445 454
35. S.J. Sontag, B.I. Hirschowitz, S. Holt Two doses of omeprazole versus placebo in symptomatic erosive esophagitis the US Multicenter Study Gastroenterology 102 1992 109 118
36. C.M. Bate, P.W. Keeling, C. O'Morain Comparison of omeprazole and cimetidine in reflux oesophagitis symptomatic endoscopic, and histologic evaluations Gut 31 1990 968 972
37. R. Carlsson, J. Dent, R. Watts Gastro-oesophageal reflux disease in primary care an international study of different treatment strategies with omeprazole-International GORD Study Group Eur J Gastroenterol Hepatol 10 1998 119 124
38. H.P. Festen, E. Schenk, G. Tan Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease short- and long-term treatment-the Dutch Study Group Am J Gastroenterol 94 1999 931 936
39. T.O. Kovacs, C.M. Wilcox, K. DeVault Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive esophagitis a randomized, active-controlled, double-blind study Aliment Pharmacol Ther 16 2002 2043 2052
40. T. Scholten, G. Gatz, U. Hole Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms Aliment Pharmacol Ther 18 2003 587 594
41. J.E. Richter, W. Bochenek Oral pantoprazole for erosive esophagitis a placebo-controlled, randomized clinical trial-Pantoprazole US GERD Study Group Am J Gastroenterol 95 2000 3071 3080
42. M. Hassan-Alin, T. Andersson, E. Bredberg Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects Eur J Clin Pharmacol 56 2000 665 670
43. T. Andersson, J. Holmberg, K. Rohss Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole Br J Clin Pharmacol 45 1998 369 374
44. L.S. Welage, R.R. Berardi Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases J Pharm Assoc (Wash) 40 2000 52 62
45. Nexium prescribing information 2004 AstraZeneca, Inc Wilmington, DE
46. Prevacid prescribing information 2004 Tap Pharmaceuticals Lake Forest, IL
47. Prilosec prescribing information 2004 AstraZeneca, Inc Wilmington, DE
48. K.D. Bardhan, S. Muller-Lissner, M.A. Bigard Symptomatic gastro-oesophageal reflux disease double-blind controlled study of intermittent treatment with omeprazole or ranitidine BMJ 318 1999 502 507
49. J.G. Hatlebakk Gastric acidity comparison of esomeprazole with other proton pump inhibitors Aliment Pharmacol Ther 17 Suppl 1 2003 10 15
50. K. Rohss, T. Lind, C. Wilder-Smith Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms Eur J Clin Pharmacol 60 2004 531 539
51. R.A. Blum, H. Shi, M.D. Karol The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion Clin Ther 19 1997 1013 1023
52. P. Miner, P. Katz, Y. Chen Gastric acid control with esomeprazole, lansoprazole, pantoprazole, and rabeprazole a five-way crossover study Am J Gastroenterol 98 2003 2616 2620